210 related articles for article (PubMed ID: 14767551)
21. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
22. [Conservative approach for breast cancer. The experience of the European Institute of Oncology].
Gentilini O; Veronesi P; Gatti G; Intra M; Mazzarol G; Trifirò G; Bassi F; Caliskan M; Da Lima L; Galimberti V; Luini A
Minerva Chir; 2007 Dec; 62(6):447-58. PubMed ID: 18091655
[TBL] [Abstract][Full Text] [Related]
23. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
24. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
25. [The role of sentinel node biopsy in breast cancer surgery].
Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL
Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445
[TBL] [Abstract][Full Text] [Related]
26. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of sentinel lymph node biopsy in male breast cancer.
Cimmino VM; Degnim AC; Sabel MS; Diehl KM; Newman LA; Chang AE
J Surg Oncol; 2004 May; 86(2):74-7. PubMed ID: 15112248
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.
Boughey JC; Bedrosian I; Meric-Bernstam F; Ross MI; Kuerer HM; Akins JS; Giordano SH; Babiera GV; Ames FC; Hunt KK
J Am Coll Surg; 2006 Oct; 203(4):475-80. PubMed ID: 17000390
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
30. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant induction chemotherapy.
Schwartz G
Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Catzeddu T; Bertelli G; Del Mastro L; Venturini M
J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
[TBL] [Abstract][Full Text] [Related]
33. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
[TBL] [Abstract][Full Text] [Related]
34. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
37. Changes in male breast cancer over a 30-year period.
Schaub NP; Maloney N; Schneider H; Feliberti E; Perry R
Am Surg; 2008 Aug; 74(8):707-11; discussion 711-2. PubMed ID: 18705571
[TBL] [Abstract][Full Text] [Related]
38. The value of sentinel lymph node biopsy in elderly breast cancer patients.
Hieken TJ; Nettnin S; Velasco JM
Am J Surg; 2004 Oct; 188(4):440-2. PubMed ID: 15474445
[TBL] [Abstract][Full Text] [Related]
39. Axillary lymph node dose with tangential breast irradiation.
Reed DR; Lindsley SK; Mann GN; Austin-Seymour M; Korssjoen T; Anderson BO; Moe R
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):358-64. PubMed ID: 15667953
[TBL] [Abstract][Full Text] [Related]
40. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
White RL; Wilke LG
Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
